T. Dvorak

Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.

H. Ehrlich, T. Vesikari, R. Fritz, 2014, The Journal of infectious diseases.

Efficacy and safety of pegylated full‐length recombinant factor VIII with extended half‐life for perioperative haemostasis in haemophilia A patients

B. Abbuehl, R. Gruppo, L. Griškevičius, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

H. Ehrlich, B. Luft, P. Kremsner, 2013, The Lancet. Infectious diseases.

A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

P. Kremsner, R. Aschoff, M. Zeitlinger, 2014, Clinical and Vaccine Immunology.

A Novel Multivalent OspA Vaccine against Lyme Borreliosis is Safe and 1

M. Zeitlinger, Meral Esen, G. Peter, 2014 .

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients

H. Ehrlich, M. Zeitlinger, R. Fritz, 2014, Clinical and Vaccine Immunology.